Anavex Presents New Data on Preclinical Development of ANAVEX 3-71
Go back to Anavex Presents New Data on Preclinical Development of ANAVEX 3-71| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 3.12 -0.27 (7.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $8.30 | |||
| Open | $3.34 | 52 Week Low | $2.43 | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.09 | EPS | $-0.22 | |||
| Volume | 491,719 | |||||

